Effects of a Personalized Physical Training to Reduce Fatigue
OFF2HEALTH
2 other identifiers
interventional
130
1 country
1
Brief Summary
Chronic fatigue (CF) is a pathological fatigue over at least 6 months, without improvement after rest or sleep. In primary care, it is the major complaint in 5 to 10% of the consultations. Physical activity is an efficient therapy to help reducing this fatigue in addition to the improvement of muscular and cardiorespiratory functions. However, it remains little exploited. Yet the studies focus mainly on precise chronic pathologies with general trainings, without considering the fatigue status and reveal a large heterogeneity. Personalizing the physical training appears to be the next step in order to improve chronic fatigue patients care. The objective of this study will be to investigate the relevance and the effects of a personalized physical training to reduce fatigue in chronic fatigue patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedStudy Start
First participant enrolled
September 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 8, 2027
September 20, 2024
September 1, 2024
4.1 years
June 2, 2023
September 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome is the change in the FACIT-F score obtained before and after the exercise procedure.
The FACIT-F (Functional Assessment of Chronic Illness Therapy) is a short questionnaire consisting of 13 questions which the patient answers on a scale of 0 to 4. The scores are simply added together, inverting the scale for negative sentences, to give a result out of 52 points. The lower the score, the greater the fatigue.
Month 1, 4
Study Arms (2)
Personalized training group with the fatigue status (PERSO)
EXPERIMENTALThe PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week. The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises.
Traditional training group following the recommendations (RECO)
ACTIVE COMPARATORThe RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume.
Interventions
Patients will be randomly assigned to the PERSO or the RECO group. Each week, fatigue status of the patients will be assessed with four evaluations: * Subjective fatigue (Rate of Fatigue scale) * Heart rate variability with a holter ECG * Muscle pain with a visual analogue scale * Muscle fatigue with muscular electrical stimulations with the Myocene® The two first correspond to an aerobic fatigue score and the two latter to a muscle fatigue score. The RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume. The PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week. The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises.
Eligibility Criteria
You may qualify if:
- Aged ≥ 18
- Men or women
- FACIT-F score ≤ 34
- Ability to walk during 10 minutes without stopping
- Ability to receive the Myocene® stimulation protocol
- Have given written consent
- Members or beneficiaries of a social security program
You may not qualify if:
- Contraindication to experimental procedures
- Important health issues that would compromise the participant security during the study
- Persistent atrial fibrillation or 2nd or 3rd degree atrioventricular block
- Currently participating in an other interventional study or having so in the past thirty days
- Patient is pregnant
- Patient is unable to give an informed consent
- Patient is deprived of liberty or under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David HUPIN, MD
CHU SAINT-ETIENNE
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2023
First Posted
June 12, 2023
Study Start
September 27, 2023
Primary Completion (Estimated)
November 8, 2027
Study Completion (Estimated)
November 8, 2027
Last Updated
September 20, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share